Profil
Stacey Bilinski currently works at IN8bio, Inc., as Vice President-Clinical Operations from 2022.
Ms. Bilinski also formerly worked at Traws Pharma, Inc., as Executive Director-Clinical Operations from 2012 to 2022 and Taiho Oncology, Inc., as Global Senior Director-Operations from 2015 to 2022.
Ms. Bilinski received her undergraduate degree from Rutgers State University of New Jersey.
Postes actifs de Stacey Bilinski
| Sociétés | Poste | Début |
|---|---|---|
| IN8BIO, INC. | Directeur Technique/Scientifique/R&D | 13/04/2022 |
Anciens postes connus de Stacey Bilinski
| Sociétés | Poste | Fin |
|---|---|---|
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of orally administered anti-cancer agents for tumor types | Directeur des opérations | 01/03/2022 |
| TRAWS PHARMA, INC. | Corporate Officer/Principal | 01/03/2022 |
Formation de Stacey Bilinski
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Traws Pharma, Inc.
Traws Pharma, Inc. BiotechnologyHealth Technology Discovers and develops products for patients with cancer | Health Technology |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of orally administered anti-cancer agents for tumor types | Health Technology |
IN8bio, Inc.
IN8bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer | Health Technology |
















